Literature DB >> 21387185

RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy.

Manuela Malatesta1, Marzia Giagnacovo, Rosanna Cardani, Giovanni Meola, Carlo Pellicciari.   

Abstract

Myotonic dystrophies (DMs) are characterised by highly variable clinical manifestations consisting of muscle weakness and atrophy, and a wide spectrum of extramuscular manifestations. In both DM1 and DM2 forms, expanded nucleotide sequences cause the accumulation of mutant transcripts in the nucleus, thus deregulating the function of some RNA-binding proteins and providing a plausible explanation for the multifactorial phenotype of DM patients. However, at the skeletal muscle level, no mechanistic explanation for the muscle wasting has so far been proposed. We therefore performed a study in situ by immunoelectron microscopy on biceps brachii biopsies from DM1, DM2 and healthy subjects, providing the first ultrastructural evidence on the distribution of some nuclear ribonucleoprotein (RNP)-containing structures and molecular factors involved in pre-mRNA transcription and maturation in dystrophic myonuclei. Our results demonstrated an accumulation of splicing and cleavage factors in myonuclei of both DM1 and DM2 patients, suggesting an impairment of post-transcriptional pre-mRNA pathways. The transcription of the expanded sequences in DM myonuclei would therefore hamper functionality of the whole splicing machinery, slowing down the intranuclear molecular trafficking; this would reduce the capability of myonuclei to respond to anabolic stimuli thus contributing to muscle wasting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21387185     DOI: 10.1007/s00418-011-0797-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  52 in total

Review 1.  Universal nuclear domains of somatic and germ cells: some lessons from oocyte interchromatin granule cluster and Cajal body structure and molecular composition.

Authors:  Dmitry Bogolyubov; Irina Stepanova; Vladimir Parfenov
Journal:  Bioessays       Date:  2009-04       Impact factor: 4.345

2.  Aging affects the distribution of the circadian CLOCK protein in rat hepatocytes.

Authors:  Manuela Malatesta; Beatrice Baldelli; Serafina Battistelli; Patrizia Fattoretti; Carlo Bertoni-Freddari
Journal:  Microsc Res Tech       Date:  2005-09       Impact factor: 2.769

Review 3.  The regulation of INK4/ARF in cancer and aging.

Authors:  William Y Kim; Norman E Sharpless
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

4.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

5.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

7.  Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles.

Authors:  Manuela Malatesta; Federica Perdoni; Sylviane Muller; Carlo Pellicciari; Carlo Zancanaro
Journal:  J Biomed Biotechnol       Date:  2010-05-19

8.  RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study.

Authors:  F Perdoni; M Malatesta; R Cardani; M Giagnacovo; E Mancinelli; G Meola; C Pellicciari
Journal:  Eur J Histochem       Date:  2009-09-23       Impact factor: 3.188

9.  Pentamidine reverses the splicing defects associated with myotonic dystrophy.

Authors:  M Bryan Warf; Masayuki Nakamori; Catherine M Matthys; Charles A Thornton; J Andrew Berglund
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

10.  Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ.

Authors:  M Malatesta; G Meola
Journal:  Eur J Histochem       Date:  2010-10-19       Impact factor: 3.188

View more
  13 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

Review 2.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.

Authors:  M Giagnacovo; M Malatesta; R Cardani; G Meola; C Pellicciari
Journal:  Histochem Cell Biol       Date:  2012-06-17       Impact factor: 4.304

Review 4.  Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?

Authors:  M Malatesta
Journal:  Eur J Histochem       Date:  2012-08-10       Impact factor: 3.188

5.  Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence.

Authors:  M Malatesta; M Giagnacovo; L V Renna; R Cardani; G Meola; C Pellicciari
Journal:  Eur J Histochem       Date:  2011-08-27       Impact factor: 3.188

6.  Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia.

Authors:  M Malatesta; M Giagnacovo; M Costanzo; B Cisterna; R Cardani; G Meola
Journal:  Eur J Histochem       Date:  2013-04-22       Impact factor: 3.188

7.  Histochemistry as an irreplaceable approach for investigating functional cytology and histology.

Authors:  C Pellicciari
Journal:  Eur J Histochem       Date:  2013-12-19       Impact factor: 3.188

Review 8.  RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence.

Authors:  Manuela Malatesta; Rosanna Cardani; Carlo Pellicciari; Giovanni Meola
Journal:  Front Aging Neurosci       Date:  2014-07-30       Impact factor: 5.750

9.  Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.

Authors:  L V Renna; R Cardani; A Botta; G Rossi; B Fossati; E Costa; G Meola
Journal:  Eur J Histochem       Date:  2014-10-22       Impact factor: 3.188

Review 10.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.